Filed: 8/14/2026ACC: 0001104659-26-097077
📋 What this filing means
DATA COLLECTIVE IV GP, LLC filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $78.55M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$78.55M
Total AUM (reported)
11.55M
Total Shares
Allocation by class
COM CL A$26.62M33.9%
CL A ORD SHS$25.41M32.3%
CL A$21.80M27.8%
COM SHS$4.72M6.0%
Portfolio Concentration
Top 3$73.83M94.0%
4–10$4.72M6.0%
Top 3 weight
94.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 11.55M
Sole
Full voting authority
11.55M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole4
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
Evolv Technologies Holdings, Inc.
SOLEShares4.59M
TypeSH
Market value$26.62M
33.89%
Sole
4.59M
Shared
0.00
None
0.00
Horizon Quantum Holdings Ltd
SOLEShares915.20K
TypeSH
Market value$25.41M
32.34%
Sole
915.20K
Shared
0.00
None
0.00
Recursion Pharmaceuticals, Inc.
SOLEShares5.94M
TypeSH
Market value$21.80M
27.76%
Sole
5.94M
Shared
0.00
None
0.00
Definium Therapeutics, Inc. (MindMed)
SOLEShares100.35K
TypeSH
Market value$4.72M
6.01%
Sole
100.35K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Evolv Technologies Holdings, Inc.SOLE | COM CL A | 4.59M | SH | $26.62M 33.89% | 4.59M | 0.00 | 0.00 |
Horizon Quantum Holdings LtdSOLE | CL A ORD SHS | 915.20K | SH | $25.41M 32.34% | 915.20K | 0.00 | 0.00 |
Recursion Pharmaceuticals, Inc.SOLE | CL A | 5.94M | SH | $21.80M 27.76% | 5.94M | 0.00 | 0.00 |
Definium Therapeutics, Inc. (MindMed)SOLE | COM SHS | 100.35K | SH | $4.72M 6.01% | 100.35K | 0.00 | 0.00 |